{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:15:15Z","timestamp":1790511315895,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["160044"],"award-info":[{"award-number":["160044"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.nano.2019.102121","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T12:38:01Z","timestamp":1572266281000},"page":"102121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Encapsulation in lipid-core nanocapsules improves topical treatment with the potent antileishmanial compound CH8"],"prefix":"10.1016","volume":"24","author":[{"given":"Douglas O","family":"Escrivani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milene Val\u00e9ria","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Poletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stela Regina","family":"Ferrarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane J.","family":"Sousa-Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia Stanis\u00e7uaski","family":"Guterres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Raffin","family":"Pohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartira","family":"Rossi-Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2019.102121_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2019.102121_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fcimb.2012.00121","article-title":"Leishmania promastigotes: building a safe niche within macrophages","volume":"2","author":"Moradin","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.nano.2019.102121_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/815023","article-title":"Advances in development of new treatment for leishmaniasis","volume":"2015","author":"de Menezes","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.nano.2019.102121_bb0020","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1371\/journal.pntd.0000381","article-title":"Is Paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials","volume":"3","author":"Kim","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.nano.2019.102121_bb0025","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1590\/S1678-91992007000300004","article-title":"Inefficacy of the association N-methyl glucamine and topical miltefosine in the treatment of experimental cutaneous leishmaniasis by Leishmania (Leishmania) amazonensis","volume":"13","author":"Sampaio","year":"2007","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"10.1016\/j.nano.2019.102121_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006653","article-title":"A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia","volume":"12","author":"L\u00f3pez","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.nano.2019.102121_bb0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10717540500455975","article-title":"Dermal and transdermal drug delivery systems: current and future prospects","volume":"13","author":"Brown","year":"2006","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2019.102121_bb0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2012.09.032","article-title":"Penetration enhancers","volume":"64","author":"Williams","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2019.102121_bb0045","series-title":"DNDi\u2018s Strategy for Cutaneous Leishmaniasis","author":"DNDi","year":"2018"},{"key":"10.1016\/j.nano.2019.102121_bb0050","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.bmc.2005.10.005","article-title":"Synthesis of chalcone analogues with increased antileishmanial activity","volume":"14","author":"Boeck","year":"2006","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"10.1016\/j.nano.2019.102121_bb0055","doi-asserted-by":"crossref","first-page":"e00792-18","DOI":"10.1128\/AAC.00792-18","article-title":"Broad spectrum and safety of oral treatment with a promising nitrosylated chalcone in murine leishmaniasis","volume":"62","author":"Sousa-Batista","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2019.102121_bb0060","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01822-17","article-title":"Depot subcutaneous injection with chalcone CH8-loaded poly(lactic-co-glycolic acid) microspheres as a single-dose treatment of cutaneous leishmaniasis","volume":"62","author":"Sousa-Batista","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2019.102121_bb0065","first-page":"1","article-title":"Improved drug loading via spray drying of a chalcone implant for local treatment of cutaneous leishmaniasis","volume":"0","author":"Sousa-Batista","year":"2018","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.nano.2019.102121_bb0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2015.10.049","article-title":"Nanoparticles and nanofibers for topical drug delivery","volume":"240","author":"Goyal","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2019.102121_bb0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.colsurfa.2010.12.011","article-title":"Formulation of lipid core nanocapsules","volume":"375","author":"Venturini","year":"2011","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.nano.2019.102121_bb0080","first-page":"1","article-title":"Lipid-core nanocapsules increase the oral efficacy of quercetin in cutaneous leishmaniasis","author":"Sousa-Batista","year":"2017","journal-title":"Parasitology"},{"key":"10.1016\/j.nano.2019.102121_bb0085","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1111\/j.1600-0846.2012.00631.x","article-title":"Vitamin K1-loaded lipid-core nanocapsules: physicochemical characterization and in vitro skin permeation","volume":"19","author":"da Silva","year":"2013","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.nano.2019.102121_bb0090","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejps.2015.07.018","article-title":"Skin penetration behavior of lipid-core nanocapsules for simultaneous delivery of resveratrol and curcumin","volume":"78","author":"Friedrich","year":"2015","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2019.102121_bb0095","series-title":"Guide for the care and use of laboratory animals","author":"NRC","year":"2011"},{"key":"10.1016\/j.nano.2019.102121_bb0100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1166\/jnn.2015.9182","article-title":"How sorbitan monostearate can increase drug-loading capacity of lipid-core polymeric nanocapsules","volume":"15","author":"Poletto","year":"2015","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.nano.2019.102121_bb0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1166\/jcsb.2012.1015","article-title":"Fluorescent-labeled poly(\u03b5-caprolactone) lipid-core nanocapsules: synthesis, physicochemical properties and macrophage uptake","volume":"1","author":"Poletto","year":"2012","journal-title":"J Colloid Sci Biotechnol"},{"key":"10.1016\/j.nano.2019.102121_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01822-17","article-title":"Depot subcutaneous injection with chalcone CH8-loaded PLGA microspheres aiming at a single-dose treatment of cutaneous leishmaniasis","volume":"62","author":"Sousa-Batista","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2019.102121_bb0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3347\/kjp.2011.49.4.357","article-title":"Use of in vivo and in vitro systems to select Leishmania amazonensis expressing green fluorescent protein","volume":"49","author":"Costa","year":"2011","journal-title":"Korean J Parasitol"},{"key":"10.1016\/j.nano.2019.102121_bb0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0076-6879(96)68016-1","article-title":"Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction","volume":"268","author":"Granger","year":"1996","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.nano.2019.102121_bb0125","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cyto.a.20911","article-title":"Development of a novel, cell-based chemical screen to identify inhibitors of intraphagosomal lipolysis in macrophages","volume":"77","author":"VanderVen","year":"2010","journal-title":"Cytometry A"},{"key":"10.1016\/j.nano.2019.102121_bb0130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.nano.2019.102121_bb0135","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1166\/jnn.2016.11673","article-title":"Lipid-core nanocapsules improved antiedematogenic activity of tacrolimus in adjuvant-induced arthritis model","volume":"16","author":"Friedrich","year":"2016","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.nano.2019.102121_bb0140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.msec.2017.03.099","article-title":"Liquid formulation containing doxorubicin-loaded lipid-core nanocapsules: cytotoxicity in human breast cancer cell line and in vitro uptake mechanism","volume":"76","author":"Antonow","year":"2017","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.nano.2019.102121_bb0145","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.nano.2015.07.011","article-title":"Assessment of \u03b2-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB\/c mice","volume":"11","author":"Moreno","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2019.102121_bb0150","series-title":"Percutaneous penetration enhancers chemical methods in penetration enhancement: nanocarriers","first-page":"201","article-title":"Polymeric nanocapsules for topical delivery","author":"Pohlmann","year":"2016"},{"key":"10.1016\/j.nano.2019.102121_bb0155","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1751-1097.2012.01147.x","article-title":"Photostability and skin penetration of different E-resveratrol-loaded supramolecular structures","volume":"88","author":"Detoni","year":"2012","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.nano.2019.102121_bb0160","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1039\/c1sm05508a","article-title":"Diverse deformation properties of polymeric nanocapsules and lipid-core nanocapsules","volume":"7","author":"Fiel","year":"2011","journal-title":"Soft Matter"},{"key":"10.1016\/j.nano.2019.102121_bb0165","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0020-7519(02)00140-6","article-title":"Developmental changes in lysosome morphology and function Leishmania parasites","volume":"32","author":"Waller","year":"2002","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.nano.2019.102121_bb0170","first-page":"1","article-title":"The endocytosis and intracellular fate of nanomedicines: implication for rational design","volume":"8","author":"Kou","year":"2013","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.nano.2019.102121_bb0175","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1017\/S003118201300142X","article-title":"Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections","volume":"141","author":"Don","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.nano.2019.102121_bb0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejpb.2013.04.001","article-title":"In vivo toxicological evaluation of polymeric nanocapsules after intradermal administration","volume":"86","author":"Bulc\u00e3o","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2019.102121_bb0185","series-title":"Peroxynitrite, a potent macrophage-derived oxidizing cytotoxin to combat invading pathogens","first-page":"215","author":"Prolo","year":"2014"},{"key":"10.1016\/j.nano.2019.102121_bb0190","first-page":"113","article-title":"Intracellular signal modulation by nanomaterials","volume":"811","author":"Hussain","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.nano.2019.102121_bb0195","first-page":"1261","article-title":"Novel therapeutic mechanisms determine the effectiveness of lipid-core nanocapsules on melanoma models","volume":"11","author":"Drewes","year":"2016","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2019.102121_bb0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10787-016-0264-5","article-title":"The antioxidant activity of some curcuminoids and chalcones","volume":"24","author":"S\u00f6kmen","year":"2016","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.nano.2019.102121_bb0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejmech.2004.09.006","article-title":"Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents","volume":"40","author":"Won","year":"2005","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.nano.2019.102121_bb0210","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1600-0854.2005.00284.x","article-title":"The kinetics of phagosome maturation as a function of phagosome\/lysosome fusion and acquisition of hydrolytic activity","volume":"6","author":"Yates","year":"2005","journal-title":"Traffic"},{"key":"10.1016\/j.nano.2019.102121_bb0215","series-title":"Nanocosmetics and nanomedicines: new approaches for skin care","first-page":"181","article-title":"Performance of elastic liposomes for topical treatment of cutaneous leishmaniasis","author":"Rossi-Bergmann","year":"2011"},{"key":"10.1016\/j.nano.2019.102121_bb0220","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17425247.2012.666967","article-title":"Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals","volume":"9","author":"Puglia","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2019.102121_bb0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2014.01.018","article-title":"Quantification of nanoparticle uptake into hair follicles in pig ear and human forearm","volume":"179","author":"Raber","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2019.102121_bb0230","series-title":"Nanosilver in the treatment of localized cutaneous leishmaniasis caused by Leishmania major (MRHO\/IR\/75\/ER): an in vitro and in vivo study","first-page":"5","volume":"2015","author":"Mohebali","year":"2015"},{"key":"10.1016\/j.nano.2019.102121_bb0235","series-title":"Folate-modified and curcumin-loaded dendritic magnetite nanocarriers for the targeted thermo-chemotherapy of cancer cells","first-page":"330","volume":"47","author":"Montazerabadi","year":"2019"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419302059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963419302059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:32:55Z","timestamp":1778617975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963419302059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":47,"alternative-id":["S1549963419302059"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2019.102121","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Encapsulation in lipid-core nanocapsules improves topical treatment with the potent antileishmanial compound CH8","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2019.102121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102121"}}